{"AllianceGenome": "491", "HGNC": "491", "MIM": "604774", "_id": "27329", "_version": 2, "accession": {"genomic": ["AL138847.14", "AY569015.1", "CH471059.2", "CP068277.2", "FJ515851.1", "NC_000001.11", "NC_060925.1", "NG_028169.1", "NG_033073.2"], "protein": ["AAD34156.1", "AAH07059.1", "AAH58287.1", "AAQ88640.1", "AAS66984.1", "ACS13743.1", "BAF82115.1", "BAG37708.1", "EAX06583.1", "NP_055310.1", "Q9Y5C1.1"], "rna": ["AF152562.1", "AK289426.1", "AK315304.1", "AY358273.1", "BC007059.1", "BC058287.1", "BG562555.1", "BG562798.1", "BG564770.1", "NM_014495.4"], "translation": [{"protein": "BAG37708.1", "rna": "AK315304.1"}, {"protein": "AAQ88640.1", "rna": "AY358273.1"}, {"protein": "AAH58287.1", "rna": "BC058287.1"}, {"protein": "BAF82115.1", "rna": "AK289426.1"}, {"protein": "NP_055310.1", "rna": "NM_014495.4"}, {"protein": "AAH07059.1", "rna": "BC007059.1"}, {"protein": "AAD34156.1", "rna": "AF152562.1"}]}, "alias": ["ANG-5", "ANGPT5", "ANL3", "FHBL2"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2022-09-22T16:00:00.000Z", "disease_label": "familial hypobetalipoproteinemia 2", "gcep": "General Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0011505", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_df7eb35c-09a3-4df2-bf05-22aee7de3855-2022-09-22T160000.000Z", "sop": "SOP9"}}, "ensembl": {"gene": "ENSG00000132855", "protein": "ENSP00000360170", "transcript": ["ENST00000371129", "ENST00000482591", "ENST00000493994"], "translation": [{"protein": "ENSP00000360170", "rna": "ENST00000371129"}], "type_of_gene": "protein_coding"}, "entrezgene": "27329", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 15.2351664481, "exp_mis": 119.784671608, "exp_syn": 52.3388526302, "lof_z": 0.82103698215345, "mis_z": -1.52910088747252, "mu_lof": 1.09657988197e-06, "mu_mis": 1.03735250719e-05, "mu_syn": 4.38634671225e-06, "n_lof": 12.0, "n_mis": 154.0, "n_syn": 78.0, "p_li": 2.12015609401708e-07, "p_null": 0.550515467554727, "p_rec": 0.449484320429663, "syn_z": -2.19894024918437}, "bp": 1383, "cds_end": 63070488, "cds_start": 63063237, "n_exons": 7, "nonpsych": {"exp_lof": 13.6462420409, "exp_mis": 108.273635982, "exp_syn": 47.2286547835, "lof_z": 0.969373009275743, "mis_z": -1.68329491444718, "mu_lof": 1.09657988197e-06, "mu_mis": 1.03735250719e-05, "mu_syn": 4.38634671225e-06, "n_lof": 10.0, "n_mis": 143.0, "n_syn": 69.0, "p_li": 4.98616023367705e-06, "p_null": 0.382143223860733, "p_rec": 0.617851789979033, "syn_z": -1.99455486440509}, "nontcga": {"exp_lof": 14.0024097346, "exp_mis": 110.187961763, "exp_syn": 48.1377988214, "lof_z": 1.58236085618768, "mis_z": -1.2725433502907, "mu_lof": 1.09657988197e-06, "mu_mis": 1.03735250719e-05, "mu_syn": 4.38634671225e-06, "n_lof": 8.0, "n_mis": 137.0, "n_syn": 66.0, "p_li": 0.000205748714168147, "p_null": 0.0931198600523075, "p_rec": 0.906674391233524, "syn_z": -1.63009958967726}, "transcript": "ENST00000371129.3"}, "exons": [{"cdsend": 62604817, "cdsstart": 62597566, "chr": "1", "position": [[62597519, 62598061], [62598695, 62598806], [62601081, 62601196], [62601768, 62601882], [62602284, 62602380], [62603968, 62604235], [62604632, 62606313]], "strand": 1, "transcript": "NM_014495", "txend": 62606313, "txstart": 62597519}], "exons_hg19": [{"cdsend": 63070488, "cdsstart": 63063237, "chr": "1", "position": [[63063190, 63063732], [63064366, 63064477], [63066752, 63066867], [63067439, 63067553], [63067955, 63068051], [63069639, 63069906], [63070303, 63071984]], "strand": 1, "transcript": "NM_014495", "txend": 63071984, "txstart": 63063190}], "generif": [{"pubmed": 11877390, "text": "ANGPTL3 is the first member of the angiopoietin-like family of secreted factors binding to integrin alpha(v)beta(3), which suggests a possible role in the regulation of angiogenesis."}, {"pubmed": 11877390, "text": "ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo"}, {"pubmed": 12518032, "text": "Angptl3 gene is a direct target of the liver X receptor (LXR)."}, {"pubmed": 12565906, "text": "Data show that angiopoietin-like protein 3 (ANGPTL3) targets adipose cells and induces lipolysis."}, {"pubmed": 12909640, "text": "the cleavage of ANGPTL3 at two sites is important for the activation of ANGPTL3 in vivo"}, {"pubmed": 16531751, "text": "liver-derived Angptl3 inhibits lipoprotein lipase activity primarily in the fed state"}, {"pubmed": 17110602, "text": "Angptl3 acts as an inhibitor of EL and may be involved in the regulation of plasma HDL cholesterol and HDL-PL levels in humans and rodents."}, {"pubmed": 18063851, "text": "The pilot study supports the hypothesis about the role of Angptl3 as a new class of lipid metabolism modulator."}, {"pubmed": 18193043, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18193044, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18279878, "text": "probucol decreases plasma ANGPTL3 and HDL phospholipids while increasing prebeta1-HDL and cholesteryl ester transfer protein"}, {"pubmed": 18535744, "text": "Our results also indicated that the integrin alphaVbeta3 antibody (LM609) could block the Angptl3-induced protein kinase B phosphorylation."}, {"pubmed": 18596051, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18804459, "text": "ANGPTL3, the inhibitor of endothelial lipase, may be strongly associated with increased HDL-cholesterol"}, {"pubmed": 19028676, "text": "The finding that ANGPTL3 and ANGPTL4 inhibit LPL activity through distinct mechanisms indicates that the two proteins play unique roles in modulation of lipid metabolism in vivo."}, {"pubmed": 19148283, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19282754, "text": "Dysmorphic findings in two cases involving FBHL2 are reported."}, {"pubmed": 19487539, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19540497, "text": "ANGPTL3 may be a novel factor contributing to uremic dyslipidemia."}, {"pubmed": 19542565, "text": "Like ANGPTL4, ANGPTL3 inhibited nonstabilized LPL but not GPIHBP1-stabilized LPL"}, {"pubmed": 19656773, "text": "Data show that SNPs associated with TG in normolipidemic samples, including APOA5, TRIB1, TBL2, GCKR, GALNT2 and ANGPTL3 were significantly associated with HLP types 2B, 3, 4 and 5."}, {"pubmed": 19656773, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19826106, "text": "Data suggest roles for ANGPTL3 and ANGPTL4 in modulation of serum TG and HDL levels in obesity in a Finnish population sample."}, {"pubmed": 19890028, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19890028, "text": "The present study underlines the role of ANGPTL3 in HDL-cholesterol metabolism as early as in adolescence"}, {"pubmed": 20160193, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20360639, "text": "Serum Angptl3 was positively correlated with adiponectin in metabolic syndrome patients."}, {"pubmed": 20570916, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20571754, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20595410, "text": "relationship between plasma angiopoietin-like protein 3 (ANGPTL3), and lipoprotein lipase (LPL) activity and hepatic triglyceride lipase"}, {"pubmed": 20679960, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20714348, "text": "Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20837471, "text": "ANGPTL3 activation is modulated by O-glycosylation and the proprotein undergoes convertase processing for activation."}, {"pubmed": 20855565, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20942659, "text": "Found two distinct nonsense mutations in ANGPTL3 in 2 family members out of 38 with combined hypolipidemia."}, {"pubmed": 20972250, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21691831, "text": "Data show no differences in triglyceride or total cholesterol levels in relation to any allelic variants of ANGPTL3, CILP2, or TRIB1 SNPs."}, {"pubmed": 21983347, "text": "ANGPTL-2 and -3 have enhancing effect on human hematopoietic progenitor cell survival, effects requiring the CC domain of the ANGPTL molecules."}, {"pubmed": 22062970, "text": "the homozygous or compound heterozygous for ANGPTL3 loss-of-function mutations (p.G400VfsX5, p.I19LfsX22/p.N147X) had low plasma ANGPTL3 and moderately reduced low-density lipoprotein cholesterol but normal plasma high-density lipoprotein cholesterol."}, {"pubmed": 22095935, "text": "The prevalence and effect of mutations in ANGPTL3, in carriers of pathogenic autosomal dominant hypercholesterolemia mutations with unexpected low LDL-C levels."}, {"pubmed": 22155345, "text": "It denominated familial combined hypolipidemia, which consist of a biochemical phenotype of low LDLc, low apoB, low TG and, unlike APOB mutations, low HDL cholesterol, due to a loss-of-function mutation in ANGPTL3."}, {"pubmed": 22247256, "text": "In a cohort of subjects with severe primary hypobetalipoproteinemia the prevalence of ANGPTL3 gene mutations responsible for a combined hypolipidemia phenotype is about 10%."}, {"pubmed": 22659251, "text": "Familial combined hypolipidemia segregates as a recessive trait so that apolipoprotein B- and apolipoprotein A-I-containing lipoproteins are comprehensively affected only by the total deficiency of Angptl3."}, {"pubmed": 22896670, "text": "No gene-gene interaction was identified other than an interaction between SNPs in the ANGPTL3 and RXRA regions, which results in the inhibition of ApoB reduction in response to statin-FNA therapy."}, {"pubmed": 23661675, "text": "Although partial Angptl3 deficiency did not affect the activities of lipolytic enzymes, the complete absence of Angptl3 results in an increased lipoprotein lipase activity and mass and low circulating free fatty acid levels."}, {"pubmed": 23839332, "text": "Identification of loss-of-function ANGPTL3 mutation is shedding light on a possible role of ANGPTL3 at the crossroads of lipoproteins, fatty acids, and glucose metabolism. [Review]"}, {"pubmed": 23978712, "text": "HCV core represses ANGPTL-3 expression through loss of HNF-1alpha binding activity and blockage of LXR/RXR transactivation"}, {"pubmed": 24626437, "text": "ANGPTL3 is positively associated with low-density lipoprotein cholesterol and high-density lipoprotein cholesterol and not with metabolic syndrome traits including triglycerides."}, {"pubmed": 24768220, "text": "Data suggest that genetic polymorphisms in ANGPTL3 (angiopoietin-like 3 protein), TIMD4 (T cell immunoglobulin mucin-4), and apolipoproteins A5 and B are among the genetic determinants of hypertriglyceridemia in Amerindian populations. [REVIEW]"}, {"pubmed": 25495645, "text": "Data suggest that silencing of ANGPTL 3 (angiopoietin-like protein 3) improves insulin sensitivity."}, {"pubmed": 25733326, "text": "Novel mutation Y344S found in ANGPTL3 gene in two diabetic patients with familial hypobetalipoproteinemia."}, {"pubmed": 25954050, "text": "Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion"}, {"pubmed": 26639238, "text": "The present data leads to new insights into the role of ANGPTL3 in glioblastomas and provides an independent predictive factor"}, {"pubmed": 26739706, "text": "ANGPTL3 levels were associated with fasting insulin and the homeostasis model assessment of insulin resistance in Korean children."}, {"pubmed": 26800306, "text": "The ANGPTL3 gene lies within DOCK7, although the variant is within non-coding regions outside of ANGPTL3, within DOCK7, suggesting complex long-range regulatory effects on gene expression in coronary artery disease."}, {"pubmed": 27040449, "text": "Our findings demonstrate that complete ANGPTL3 deficiency associates with highly reduced postprandial lipemia probably due to faster catabolism of intestinally derived lipoproteins, larger expansion of the postprandial FFA pool, and decreased influx of dietary-derived fatty acids into the liver. These results add information on mechanisms underlying hypolipidemia in familial combined hypolipidemia (FHBL2)."}, {"pubmed": 27053679, "text": "An ANGPTL3-4-8 model was proposed to explain the variations of lipoprotein lipase (LPL) activity during the fed-fast cycle. Feeding induces ANGPTL8, activating the ANGPTL8-ANGPTL3 pathway, which inhibits LPL in cardiac and skeletal muscles to direct circulating triglycerides (TG) to white adipose tissue; the reverse is true during fasting, which suppresses ANGPTL8 but induces ANGPTL4, thereby directing TG to muscles."}, {"pubmed": 27620179, "text": "ANGPTL3 is specifically correlated with HDL-c, apoA-I, SAA and HDL function in female non-diabetic participants. The decrease of ANGPTL3 level in female T2DM patients might contribute to its weak association to HDL components and function."}, {"pubmed": 27733177, "text": "our data shows that ANGPTL3, 4 and 8 are increased in obesity and type 2 diabetes (T2D). ANGPTL8 associates with ANGPTL3 in the non-diabetic subjects while it associated more with ANGPTL4 in the obese and T2D subjects."}, {"pubmed": 28371666, "text": "circulating ANGPTL3 and ANGPTL 4 expression was significantly elevated in hepatocellular carcinoma cases compared to chronic hepatitis patients and controls"}, {"pubmed": 28385496, "text": "ANGPTL3 deficiency is associated with protection from coronary artery disease."}, {"pubmed": 28413163, "text": "ANGPTL8 has a functional LPL inhibitory motif, but only inhibits LPL and increases plasma TG levels in mice in the presence of ANGPTL3"}, {"pubmed": 28538136, "text": "participants with heterozygous loss-of-function variants in ANGPTL3 had significantly lower serum levels of triglycerides, HDL cholesterol, and LDL cholesterol than participants without these variants."}, {"pubmed": 28972399, "text": "Subjects who carried ANGPTL3 sequence variants rs12563308 and rs199772471 had abnormally high total cholesterol and LDL-cholesterol concentrations."}, {"pubmed": 29183623, "text": "Reduced secretion and increased uptake of ApoB-containing lipoproteins may contribute to the low LDL-C observed in humans with genetic ANGPTL3 deficiency."}, {"pubmed": 29334984, "text": "The role of ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases is reviewed here."}, {"pubmed": 29454388, "text": "these results suggest that the DOCK-ANGPTL3 SNPs and their haplotypes were associated with the angiographic severity to coronary artery atherosclerosis and the risk of coronary artery disease (CAD) and ischemic stroke in the Southern Chinese Han population."}, {"pubmed": 29695708, "text": "Taken together, our data suggest that serum ANGPTL3 and 4 levels are influenced by nutritional status and fasting and could be involved in the metabolic disturbances present in obesity and anorexia nervosa."}, {"pubmed": 29713054, "text": "Recently two proteins, angiopoietin-like protein 3 and 4, have emerged from genetic studies as being factors that significantly modulate plasma triglyceride levels and coronary artery disease. ..Here we report the crystal structures of the fibrinogen-like domains of both proteins. These structures offer new insights into the reported loss of function mutations"}, {"pubmed": 29989339, "text": "Association of low-density lipoprotein receptor-related protein 1 rs11613352 and angiopoietin-like 3 rs2131925 with hypertension might imply a direct effect at the artery wall."}, {"pubmed": 30683883, "text": "The authors data suggest that genetic variation of rs11207997 in the ANGPTL3 gene is associated with risk of diabetes mellitus, possibly through contributing to a lifelong set point of triglycerides."}, {"pubmed": 30782561, "text": "Twenty-three patients were genetically confirmed as affected by primary hypobetalipoproteinemia. In this group of patients, the most prevalent mutated genes were APOB (in 17 patients, with eight novel mutations identified), SAR1B (in 3 patients, with one novel mutation identified), ANGPTL3 (in 2 patients), and MTTP (in 1 patient). The other 21 patients could not be genetically diagnosed with hypobetalipoproteinemia despit"}, {"pubmed": 30827231, "text": "Rare ANGPTL3 variants were identified in Chinese patients with Familial Hypercholesterolemia, including ANGPTL3: p.(Lys319Arg) which affected the expression of ANGPTL3 and the cholesterol metabolic process"}, {"pubmed": 31054480, "text": "Hypocholesterolemia and dysregulated production of angiopoietin-like proteins in sickle cell anemia patients."}, {"pubmed": 31103046, "text": "Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria."}, {"pubmed": 31223079, "text": "Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis."}, {"pubmed": 31270029, "text": "ANGPTL3 inhibits renal cell carcinoma metastasis by inhibiting VASP phosphorylation."}, {"pubmed": 31380419, "text": "we used receiver operating characteristic curve analysis to evaluate the diagnostic performance of Angptl3 and 8 in discriminating thyroid dysfunction. The area under curve for detecting thyroid dysfunction based on Angptl3 and Angptl8 was 0.763.  Our data show that serum Angptl3 and 8 levels are increased in clinical and subclinical hypothyroid patients and that Angptl3 and 8 may serve as possible biomarkers"}, {"pubmed": 31413305, "text": "Reduced miR-181d level in obesity and its role in lipid metabolism via regulation of ANGPTL3."}, {"pubmed": 31923423, "text": "Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation."}, {"pubmed": 32151767, "text": "ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins."}, {"pubmed": 32324598, "text": "The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?"}, {"pubmed": 32332430, "text": "Homozygous familial hypercholesterolemia: what treatments are on the horizon?"}, {"pubmed": 32332431, "text": "Regulation of lipoprotein lipase-mediated lipolysis of triglycerides."}, {"pubmed": 32407781, "text": "Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity."}, {"pubmed": 32440963, "text": "The Clinical Role of Angiopoietin-Like Protein 3 in Evaluating Coronary Artery Disease in Patients with Obstructive Sleep Apnea."}, {"pubmed": 32487544, "text": "Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids."}, {"pubmed": 32510837, "text": "Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity."}, {"pubmed": 32646941, "text": "Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance."}, {"pubmed": 32777482, "text": "Angiopoietin-like protein 3, an emerging cardiometabolic therapy target with systemic and cell-autonomous functions."}, {"pubmed": 33075372, "text": "Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome."}, {"pubmed": 33273510, "text": "Serum angiopoietin-like 3 levels are elevated in obese non diabetic men but are unaffected during an oral glucose tolerance test."}, {"pubmed": 33351885, "text": "Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis."}, {"pubmed": 33482195, "text": "Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities."}, {"pubmed": 33580780, "text": "Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study."}, {"pubmed": 33588820, "text": "Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia."}, {"pubmed": 33636293, "text": "A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia."}, {"pubmed": 33762177, "text": "ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition."}, {"pubmed": 33772079, "text": "ANGPTL3 gene variants in subjects with familial combined hyperlipidemia."}, {"pubmed": 33887960, "text": "Identifying the Lipidomic Effects of a Rare Loss-of-Function Deletion in ANGPTL3."}, {"pubmed": 33927698, "text": "Maternal Serum Angiopoietin-Like 3 Levels in Healthy and Mild Preeclamptic Pregnant Women."}, {"pubmed": 34067751, "text": "ANGPTL3 Variants Associate with Lower Levels of Irisin and C-Peptide in a Cohort of Arab Individuals."}, {"pubmed": 34293055, "text": "Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes."}, {"pubmed": 34360721, "text": "Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment."}, {"pubmed": 34371033, "text": "Antisense oligonucleotide-mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice."}, {"pubmed": 34417926, "text": "The Association Between rs1748195 and rs11207997 Variants of the ANGPTL3 Gene and Susceptibility to Cardiovascular Disease in the MASHAD Cohort Study."}, {"pubmed": 34484467, "text": "ANGPTL3 Overexpression Suppresses the Development of Oncogenic Properties in Renal Cell Carcinoma via the Wnt/beta-Catenin Signaling Pathway and Predicts Good Prognosis."}, {"pubmed": 34535418, "text": "ANGPTL3 and ANGPTL8 in Thai subjects with hyperalphalipoproteinemia and severe hypertriglyceridemia."}, {"pubmed": 34684048, "text": "Serum Angiopoietin-like Protein 3 Level Is Associated with Peripheral Arterial Stiffness in Patients with Coronary Artery Disease."}, {"pubmed": 34689370, "text": "Association of ANGPTL3 polymorphisms with high-density lipoprotein cholesterol uptake capacity in patients with cardiovascular disease."}, {"pubmed": 34742313, "text": "Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity."}, {"pubmed": 34971570, "text": "Lean adolescents with insulin resistance display higher angiopoietin like protein 3, ApoC-III and chylomicron remnant dyslipidemia."}, {"pubmed": 35038961, "text": "Angiopoietin-like 3 (ANGPTL3) drives cell proliferation, migration and angiogenesis in cervical cancer via binding to integrin alpha v beta 3."}, {"pubmed": 35052431, "text": "Lipid-Associated Variants near ANGPTL3 and LPL Show Parent-of-Origin Specific Effects on Blood Lipid Levels and Obesity."}, {"pubmed": 35399079, "text": "ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome."}, {"pubmed": 35976955, "text": "Increased Levels of ANGPTL3 and CTRP9 in Patients With Obstructive Sleep Apnea and Their Relation to Insulin Resistance and Lipid Metabolism and Markers of Endothelial Dysfunction."}, {"pubmed": 35999139, "text": "Angiopoietin-like 3: An important protein in regulating lipoprotein levels."}, {"pubmed": 36163215, "text": "Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4."}, {"pubmed": 36203122, "text": "Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers."}, {"pubmed": 36253169, "text": "ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content."}, {"pubmed": 36416040, "text": "Evaluation of rs1748195 ANGPTL3 gene polymorphism in patients with angiographic coronary artery disease compared to healthy individuals."}, {"pubmed": 36692110, "text": "Angiopoietin-like protein 3 promotes colorectal cancer progression and liver metastasis partly via the mitogen-activated protein kinase 14 pathway."}, {"pubmed": 36768809, "text": "The ANGPTL3-4-8 Axis in Normal Gestation and in Gestational Diabetes, and Its Potential Involvement in Fetal Growth."}, {"pubmed": 37312105, "text": "Elevated angiopoietin-like protein 3 serum levels in diabetic nephropathy patients and its association with renal function and lipid profile."}, {"pubmed": 37634084, "text": "ANGPTL3 negatively regulates IL-1beta-induced NF-kappaB activation by inhibiting the IL1R1-associated signaling complex assembly."}, {"pubmed": 37712257, "text": "ANGPTL3 Deficiency and Risk of Hepatic Steatosis."}, {"pubmed": 37889183, "text": "ANGPTL3 (Angiopoietin-Like 3) Preferentially Resides on High-Density Lipoprotein in the Human Circulation, Affecting Its Activity."}, {"pubmed": 38219820, "text": "ANGPTL3 deficiency impairs lipoprotein production and produces adaptive changes in hepatic lipid metabolism."}, {"pubmed": 38385290, "text": "ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization."}, {"pubmed": 38414008, "text": "Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary."}, {"pubmed": 38425231, "text": "Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease."}, {"pubmed": 38462608, "text": "ANGPTL3 is a novel HDL component that regulates HDL function."}, {"pubmed": 38634215, "text": "Association of a genetic variant in angiopoietin-like 3 with serum HDL-C and risk of cardiovascular disease: A study of the MASHAD cohort over 6 years."}], "genomic_pos": {"chr": "1", "end": 62606313, "ensemblgene": "ENSG00000132855", "start": 62597520, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 63071830, "start": 63063158, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006071", "pubmed": 12565906, "qualifier": "involved_in", "term": "glycerol metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006631", "pubmed": 12565906, "qualifier": "involved_in", "term": "fatty acid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006644", "pubmed": 17110602, "qualifier": "involved_in", "term": "phospholipid metabolic process"}, {"evidence": "IPI", "gocategory": "BP", "id": "GO:0007160", "pubmed": 11877390, "qualifier": "involved_in", "term": "cell-matrix adhesion"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0007165", "pubmed": 11877390, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007229", "pubmed": 11877390, "qualifier": "involved_in", "term": "integrin-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0008203", "pubmed": 17110602, "qualifier": "involved_in", "term": "cholesterol metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009395", "qualifier": "involved_in", "term": "phospholipid catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0009395", "pubmed": 17110602, "qualifier": "involved_in", "term": "phospholipid catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009725", "qualifier": "involved_in", "term": "response to hormone"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0010519", "qualifier": "involved_in", "term": "negative regulation of phospholipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010519", "pubmed": 17110602, "qualifier": "involved_in", "term": "negative regulation of phospholipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0019915", "pubmed": 12565906, "qualifier": "involved_in", "term": "lipid storage"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030335", "pubmed": 11877390, "qualifier": "involved_in", "term": "positive regulation of cell migration"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0042632", "qualifier": "involved_in", "term": "cholesterol homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0042632", "pubmed": 17110602, "qualifier": "involved_in", "term": "cholesterol homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045766", "pubmed": 11877390, "qualifier": "involved_in", "term": "positive regulation of angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048844", "qualifier": "involved_in", "term": "artery morphogenesis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0050996", "pubmed": 12565906, "qualifier": "involved_in", "term": "positive regulation of lipid catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051005", "pubmed": [17110602, 19542565], "qualifier": "involved_in", "term": "negative regulation of lipoprotein lipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0055088", "pubmed": 17110602, "qualifier": "involved_in", "term": "lipid homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0055090", "pubmed": 17110602, "qualifier": "involved_in", "term": "acylglycerol homeostasis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0055091", "qualifier": "involved_in", "term": "phospholipid homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0055091", "pubmed": 17110602, "qualifier": "involved_in", "term": "phospholipid homeostasis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0070328", "qualifier": "involved_in", "term": "triglyceride homeostasis"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0070328", "pubmed": 23150577, "qualifier": "acts_upstream_of_or_within", "term": "triglyceride homeostasis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0070328", "qualifier": "involved_in", "term": "triglyceride homeostasis"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 17110602, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005769", "qualifier": "located_in", "term": "early endosome"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005794", "qualifier": "located_in", "term": "Golgi apparatus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0009986", "pubmed": 12565906, "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030027", "qualifier": "located_in", "term": "lamellipodium"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0062023", "qualifier": "is_active_in", "term": "collagen-containing extracellular matrix"}], "MF": [{"category": "MF", "evidence": "ISS", "id": "GO:0004857", "qualifier": "enables", "term": "enzyme inhibitor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004859", "pubmed": 17110602, "qualifier": "enables", "term": "phospholipase inhibitor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005178", "pubmed": 11877390, "qualifier": "enables", "term": "integrin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008083", "pubmed": 11877390, "qualifier": "enables", "term": "growth factor activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0008201", "qualifier": "enables", "term": "heparin binding"}]}, "homologene": {"genes": [[7955, 114421], [8364, 496885], [9031, 100189558], [9544, 695499], [9598, 742370], [9606, 27329], [9615, 102152922], [9913, 782603], [10090, 30924], [10116, 502970]], "id": 8499}, "interpro": [{"desc": "Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain", "id": "IPR002181", "short_desc": "Fibrinogen_a/b/g_C_dom"}, {"desc": "Fibrinogen, alpha/beta/gamma chain, C-terminal globular, subdomain 1", "id": "IPR014716", "short_desc": "Fibrinogen_a/b/g_C_1"}, {"desc": "Fibrinogen-like, C-terminal", "id": "IPR036056", "short_desc": "Fibrinogen-like_C"}], "ipi": "IPI00004957", "map_location": "1p31.3", "name": "angiopoietin like 3", "other_names": ["angiopoietin 5", "angiopoietin-related protein 3"], "pantherdb": {"HGNC": "491", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1353627", "ortholog_type": "LDO", "panther_family": "PTHR19143", "taxid": 10090, "uniprot_kb": "Q9R182"}, {"RGD": "1564505", "ortholog_type": "LDO", "panther_family": "PTHR19143", "taxid": 10116, "uniprot_kb": "F7FHP0"}, {"Ensembl": "ENSGALG00000010978", "ortholog_type": "LDO", "panther_family": "PTHR19143", "taxid": 9031, "uniprot_kb": "A0A1L1RZA5"}, {"ZFIN": "ZDB-GENE-010817-3", "ortholog_type": "LDO", "panther_family": "PTHR19143", "taxid": 7955, "uniprot_kb": "F1QYL5"}], "uniprot_kb": "Q9Y5C1"}, "pathway": {"kegg": {"id": "hsa04979", "name": "Cholesterol metabolism - Homo sapiens (human)"}, "pid": {"id": "avb3_integrin_pathway", "name": "Integrins in angiogenesis"}, "reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-174824", "name": "Plasma lipoprotein assembly, remodeling, and clearance"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-8963889", "name": "Assembly of active LPL and LIPC lipase complexes"}, {"id": "R-HSA-8963899", "name": "Plasma lipoprotein remodeling"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9024446", "name": "NR1H2 and NR1H3-mediated signaling"}, {"id": "R-HSA-9029558", "name": "NR1H2 & NR1H3 regulate gene expression linked to lipogenesis"}]}, "pdb": "6EUA", "pfam": "PF00147", "pharmgkb": "PA24796", "pharos": {"target_id": 1804, "tdl": "Tclin"}, "prosite": "PS51406", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF264359", "relationship": "is"}, {"id": "GNF264360", "relationship": "is"}, {"id": "GNF264361", "relationship": "is"}, {"id": "GNF264362", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079544", "relationship": "is"}, {"id": "GNF079545", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051046", "relationship": "is"}, {"id": "GNF055814", "relationship": "is"}, {"id": "GNF060500", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF066441", "relationship": "is"}, {"id": "GNF066442", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF000459", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF336182", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF094473", "relationship": "is"}, {"id": "GNF134130", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_028169.1", "NG_033073.2"], "protein": "NP_055310.1", "rna": "NM_014495.4", "translation": {"protein": "NP_055310.1", "rna": "NM_014495.4"}}, "reporter": {"HG-U133_Plus_2": ["219803_at", "231684_at", "243799_x_at"], "HTA-2_0": "TC01000708.hg.1", "HuEx-1_0": "2339454", "HuGene-1_1": "7901883", "HuGene-2_1": "16665461"}, "retired": [10119, 54222], "summary": "This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metabolism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2. [provided by RefSeq, Aug 2015].", "symbol": "ANGPTL3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412401"}, "unigene": "Hs.209153", "uniprot": {"Swiss-Prot": "Q9Y5C1"}, "wikipedia": {"url_stub": "ANGPTL3"}}